<DOC>
	<DOCNO>NCT01308476</DOCNO>
	<brief_summary>6 month open label non-interventional observational study acc § 4 , section 23 § 67 , section 6 German Medicines Act two parallel group 1. SMS group receive daily SMS - reminder inhale Spiriva® 18 Microgram 2. control group receive daily SMS reminder</brief_summary>
	<brief_title>SMS Reminder Assess Adherence</brief_title>
	<detailed_description>Purpose : Study Design : observational</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion : Chronic obstructive pulmonary disease ( COPD ) patient require longacting bronchodilator accord approve Summary Product Characteristics ( SPC ) guideline User mobile phone Exclusion criterion : Patients present general specific contraindication list Patient Information Leaflet SPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>